Delivery Order SPE2DB22D3004-SPE2DB25FSA19
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,778.20 to AmerisourceBergen Drug Corp for ZENPEP DR 40,000 Unit Capsule 100s on September 19, 2025, with an ultimate completion date of September 22, 2025. This firm fixed-price delivery order, which was competitively awarded without set-aside provisions, will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. ZENPEP is a pancreatic enzyme replacement therapy used to treat pancreatic...
- The Defense Logistics Agency awarded a delivery order valued at $2,406.60 to AmerisourceBergen Drug Corp for ZENPEP (pancrelipase) 40,000 unit capsules in quantities of 100 per bottle. This competitive award, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a firm fixed-price delivery order with no set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters and a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for ZENPEP DR 40,000 unit capsules (100-count bottles) with a ceiling value of $4,127.11. This firm fixed price delivery order, which achieves ultimate completion on July 24, 2025, represents a competitively awarded non-set-aside contract with performance at the vendor's Conshohocken, Pennsylvania location. ZENPEP is a pancreatic enzyme replacement therapy used to treat pancreatic...
- The Defense Logistics Agency awarded a delivery order valued at $31,256.47 to AmerisourceBergen Drug Corp for 100,000 units of Zenpep DR 40,000 unit capsules, with completion targeted for September 17, 2025. This firm fixed-price delivery order was competitively awarded without set-aside provisions and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which carries a $999,999,999.00 ceiling value and extends through...
- This is a $9,017.93 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,908,548 units of the drug ZENPEP DR 40,000 UNIT CAPSULE 100S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,199.06 contract is for the supply of 4,567,790,837 units of the drug ZENPEP (40,000 units per capsule, 100 capsules per bottle). The award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ZENPEP DR 40,000 UNIT CAPSULE 100S. The order has a firm fixed price of $17,434.88 and a period of performance through May 30, 2025. The contract is not set aside and represents open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a...
- This federal contract award from the Defense Logistics Agency (DLA) is a Firm Fixed Price Delivery Order issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $52,697.70 contract is for the supply of 40,000-unit capsules of the drug ZENPEP DR, with an ultimate completion date of November 21, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 4,564,119,421 Zenpep DR 40,000 unit capsules in 100 count bottles. The contract award amount is $10,270.09 and has an ultimate completion date of April 1, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, which...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 20,000 unit capsules of the drug ZENPEP DR 100S. The $2,972.08 firm fixed-price contract has a completion date of February 20, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FSA19Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,186.93 to AmerisourceBergen Drug Corp for 100 units of ZENPEP DR 40,000 capsules. This competitive award was issued on August 15, 2025, with an ultimate completion date of August 18, 2025, and is structured as a firm fixed-price delivery order. The contractor will perform fulfillment from its corporate office location in Conshohocken, Pennsylvania. ZENPEP is a pancreatic enzyme replacement therapy used to treat pancreatic insufficiency, representing a specialized pharmaceutical supply need within the federal medical procurement ecosystem. This delivery order was issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp leverages this prime contract vehicle to supply a wide range of medications and medical supplies to support military healthcare programs and other federal healthcare systems worldwide. The company has demonstrated consistent capability in meeting federal procurement requirements through open competition, with this delivery order exemplifying its role in delivering specialized pharmaceutical products to support Department of Defense medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 8/15/25 |